Suppr超能文献

由于过早的癌症相关死亡导致的生产力损失的成本:癌症负担的经济衡量指标。

The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden.

机构信息

National College of Ireland, Mayor Street, Dublin 1, Ireland.

出版信息

BMC Cancer. 2014 Mar 26;14:224. doi: 10.1186/1471-2407-14-224.

Abstract

BACKGROUND

Most measures of the cancer burden take a public health perspective. Cancer also has a significant economic impact on society. To assess this economic burden, we estimated years of potential productive life lost (YPPLL) and costs of lost productivity due to premature cancer-related mortality in Ireland.

METHODS

All cancers combined and the 10 sites accounting for most deaths in men and in women were considered. To compute YPPLL, deaths in 5-year age-bands between 15 and 64 years were multiplied by average working-life expectancy. Valuation of costs, using the human capital approach, involved multiplying YPPLL by age-and-gender specific gross wages, and adjusting for unemployment and workforce participation. Sensitivity analyses were conducted around retirement age and wage growth, labour force participation, employment and discount rates, and to explore the impact of including household production and caring costs. Costs were expressed in €2009.

RESULTS

Total YPPLL was lower in men than women (men = 10,873; women = 12,119). Premature cancer-related mortality costs were higher in men (men: total cost = €332 million, cost/death = €290,172, cost/YPPLL = €30,558; women: total cost = €177 million, cost/death = €159,959, cost/YPPLL = €14,628). Lung cancer had the highest premature mortality cost (€84.0 million; 16.5% of total costs), followed by cancers of the colorectum (€49.6 million; 9.7%), breast (€49.4 million; 9.7%) and brain & CNS (€42.4 million: 8.3%). The total economic cost of premature cancer-related mortality in Ireland amounted to €509.5 million or 0.3% of gross domestic product. An increase of one year in the retirement age increased the total all-cancer premature mortality cost by 9.9% for men and 5.9% for women. The inclusion of household production and caring costs increased the total cost to €945.7 million.

CONCLUSION

Lost productivity costs due to cancer-related premature mortality are significant. The higher premature mortality cost in males than females reflects higher wages and rates of workforce participation. Productivity costs provide an alternative perspective on the cancer burden on society and may inform cancer control policy decisions.

摘要

背景

大多数癌症负担的衡量标准都从公共卫生角度出发。癌症对社会也有重大的经济影响。为了评估这种经济负担,我们估算了爱尔兰因癌症过早死亡而导致的潜在工作年限损失(YPPLL)和生产力损失成本。

方法

综合考虑所有癌症,以及在男性和女性中导致大多数死亡的 10 个部位。为了计算 YPPLL,我们将 15 至 64 岁之间每 5 岁一组的死亡人数乘以平均工作寿命预期。使用人力资本方法来评估成本,涉及将 YPPLL 乘以年龄和性别特定的总工资,并根据失业率和劳动力参与率进行调整。我们还围绕退休年龄和工资增长率、劳动力参与率、就业率和贴现率进行了敏感性分析,并探讨了包括家庭生产和护理成本的影响。成本以 2009 年的欧元表示。

结果

男性的总 YPPLL 低于女性(男性:10873;女性:12119)。男性因癌症过早死亡的相关成本更高(男性:总成本=3.32 亿欧元,每例死亡成本=290172 欧元,每 YPPLL 成本=30558 欧元;女性:总成本=1.77 亿欧元,每例死亡成本=159959 欧元,每 YPPLL 成本=14628 欧元)。肺癌导致的过早死亡成本最高(8400 万欧元;占总成本的 16.5%),其次是结直肠癌(4960 万欧元;占 9.7%)、乳腺癌(4940 万欧元;占 9.7%)和脑及中枢神经系统癌症(4240 万欧元;占 8.3%)。爱尔兰因癌症过早死亡导致的总经济成本为 5.095 亿欧元,占国内生产总值的 0.3%。男性和女性退休年龄每增加一年,所有癌症过早死亡的总成本将分别增加 9.9%和 5.9%。纳入家庭生产和护理成本将总成本增加到 9.457 亿欧元。

结论

因癌症过早死亡导致的生产力损失成本巨大。男性的过早死亡率成本高于女性,反映了更高的工资和劳动力参与率。生产力成本为社会癌症负担提供了另一个视角,可能为癌症控制政策决策提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b2/3986872/b48ba687f703/1471-2407-14-224-1.jpg

相似文献

2
Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe.
Int J Cancer. 2015 Feb 15;136(4):E136-45. doi: 10.1002/ijc.29105. Epub 2014 Sep 4.
3
Years of potential life lost and productivity costs due to premature mortality from six priority diseases in Tanzania, 2006-2015.
PLoS One. 2020 Jun 9;15(6):e0234300. doi: 10.1371/journal.pone.0234300. eCollection 2020.
4
The economic impact of cancer mortality among working-age individuals in Brazil from 2001 to 2030.
Cancer Epidemiol. 2023 Oct;86:102438. doi: 10.1016/j.canep.2023.102438. Epub 2023 Aug 12.
5
The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study.
Eur J Health Econ. 2022 Mar;23(2):249-259. doi: 10.1007/s10198-021-01351-8. Epub 2021 Aug 21.
6
Projecting productivity losses for cancer-related mortality 2011 - 2030.
BMC Cancer. 2016 Oct 18;16(1):804. doi: 10.1186/s12885-016-2854-4.
7
Estimating the Economic Burden of Premature Mortality Caused by Cancer in Iran: 2006-2010.
Asian Pac J Cancer Prev. 2016;17(4):2131-6. doi: 10.7314/apjcp.2016.17.4.2131.
9
The Lost Productivity Cost of Premature Mortality Owing to Cancers in Iran: Evidence From the GLOBOCAN 2012 to 2018 Estimates.
Value Health Reg Issues. 2022 Sep;31:1-9. doi: 10.1016/j.vhri.2022.02.002. Epub 2022 Mar 18.
10
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018-2040.
Appl Health Econ Health Policy. 2023 Nov;21(6):877-889. doi: 10.1007/s40258-023-00824-6. Epub 2023 Aug 8.

引用本文的文献

1
Macrolevel Analysis of Labour Productivity Losses Associated With Breast Cancer Among Women in 47 African Countries.
Glob Health Epidemiol Genom. 2025 Jul 15;2025:4330365. doi: 10.1155/ghe3/4330365. eCollection 2025.
2
Clinically meaningful outcomes in refractory metastatic colorectal cancer: a decade of defining and raising the bar.
ESMO Open. 2024 Nov;9(11):103931. doi: 10.1016/j.esmoop.2024.103931. Epub 2024 Oct 11.
4
The construction of a novel prognostic prediction model for glioma based on GWAS-identified prognostic-related risk loci.
Open Med (Wars). 2024 Mar 15;19(1):20240895. doi: 10.1515/med-2024-0895. eCollection 2024.
7
Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancer.
Eur J Health Econ. 2024 Jul;25(5):775-785. doi: 10.1007/s10198-023-01624-4. Epub 2023 Aug 7.
8
A systemmatic literature review on indirect costs of women with breast cancer.
Cost Eff Resour Alloc. 2022 Dec 12;20(1):68. doi: 10.1186/s12962-022-00408-6.
9
Early onset colorectal cancer: Challenges across the cancer care continuum.
Ann Med Surg (Lond). 2022 Aug 22;82:104453. doi: 10.1016/j.amsu.2022.104453. eCollection 2022 Oct.
10
A Primer to Cost-Effectiveness Analysis in Breast Cancer Imaging: A Review of the Literature.
Cureus. 2022 Aug 24;14(8):e28356. doi: 10.7759/cureus.28356. eCollection 2022 Aug.

本文引用的文献

1
Time costs associated with informal care for colorectal cancer: an investigation of the impact of alternative valuation methods.
Appl Health Econ Health Policy. 2013 Jun;11(3):193-203. doi: 10.1007/s40258-013-0013-5.
2
Work-related productivity losses in an era of ageing populations: the case of colorectal cancer.
J Occup Environ Med. 2013 Feb;55(2):128-34. doi: 10.1097/JOM.0b013e3182820553.
3
Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions.
Lancet. 2012 Nov 24;380(9856):1840-50. doi: 10.1016/S0140-6736(12)60919-2. Epub 2012 Oct 16.
4
Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach.
Value Health. 2012 May;15(3):429-36. doi: 10.1016/j.jval.2011.12.012. Epub 2012 Feb 17.
5
Pancreatic cancer, healthcare cost, and loss of productivity: a register-based approach.
World J Surg. 2011 Oct;35(10):2298-305. doi: 10.1007/s00268-011-1208-2.
6
Cost of care for colorectal cancer in Ireland: a health care payer perspective.
Eur J Health Econ. 2012 Aug;13(4):511-24. doi: 10.1007/s10198-011-0325-z. Epub 2011 Jun 3.
8
Global cancer statistics.
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
9
The costs of breast cancer prior to and following diagnosis.
Eur J Health Econ. 2011 Aug;12(4):311-7. doi: 10.1007/s10198-010-0237-3. Epub 2010 Mar 20.
10
Employment and work-related issues in cancer survivors.
Crit Rev Oncol Hematol. 2011 Feb;77(2):109-30. doi: 10.1016/j.critrevonc.2010.01.004. Epub 2010 Feb 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验